As a response to advances that have occurred in psychopharmacology education and training and prescriptive authority legislation in recent years, APA has established a process to designate postdoctoral education and training programs in psychopharmacology.
This committee is composed of six members and is responsible for oversight and implementation of the designation system for psychopharmacology education and training programs. The purpose of this designation is to afford public recognition of education and training programs that meet certain minimum standards and published criteria, which are set forth in Designation Criteria for Postdoctoral Education and Training Programs in Psychopharmacology for Prescriptive Authority (PDF, 155KB)opens in new window, approved by the APA Council of Representatives in August 2009.
The next meeting of the RxP Designation Committee will be held on September 25 and October 2, 2026.
The process of designation is voluntary, to be initiated by the program seeking designation, and shall be governed by policies and procedures (PDF, 32KB)opens in new window.
For any further questions, please contact Allison Gillens.